MTOR and in situ carcinoma: The observed lower concentrations of kidney p-mTOR (phosphorylated mammalian target of rapamycin) in CIS-treated Gal-3 KO mice compared to those in CIS-treated Gal-3 wild-type mice align with the well-established role of mTOR in suppressing autophagy.